Testing blood for grass or birch allergy antibodies
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study looks at your blood to find allergy-related antibodies if you have pollen allergies to grass or birch. It may help researchers better understand what in the immune system drives allergy symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re over 18 years old
- You have a history of hay-fever type allergies (allergic rhinitis), eye allergy (conjunctivitis), or asthma caused by grass or birch pollen
- You must agree in writing to give blood and to allow the study team to do experimental work with your blood
- You have NOT taken corticosteroid medicines right before the study (see timing below)
- You have NOT taken corticosteroids by mouth in the last 10 days, or as long-acting shots in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a type of immune cell (B regulatory cell) in the blood of people with and without allergies to pollens, house dust mites, or insect stings. It aims to help understand how these cells work in allergic disease.
This study looks at how pollution from nitrogen in the environment affects pollen allergies in Belgium. It may help explain why your allergy symptoms change depending on where you live.
This study looks at how older adults (60+) with different histories of birch pollen allergy tolerate nasal exposure to birch pollen. It may help researchers understand why some people lose their allergy symptoms with age.
This study looks at how allergic reactions to cat or birch allergens affect people. It aims to find and describe adults and children with these allergies, which may help develop better treatments.
This study checks whether a new blood test can measure allergy-related immune signals (IgE) in people with known or suspected allergies. If it works well, it could help doctors diagnose and track IgE allergies more easily.
This phase 3 trial tests a specific allergy treatment (an “immunotherapy” shot) for people whose symptoms are triggered by grass and cypress tree pollen. It aims to see if the treatment is safer and more effective at reducing allergy symptoms over time, especially for nose/eye symptoms and some people with asthma.
Hear when a new Pollen Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.